Search
XNAS • Healthcare

Roivant Sciences Ltd. (ROIV)

PHARMACEUTICAL PREPARATIONS · 7TH FLOOR, 50 BROADWAY, LONDON, SW1H 0DB

XNASstockActive listing
34.70
+1.17 (+3.49%)
Quote updated 10/19/2026, 4:00:00 AM
Previous close33.53
Open33.78
Day range33.60 – 35.14
52-week range17.28 – 42.50
Volume6,334,280
Market cap25.54B
PRICE HISTORY

Stock price history and performance

Daily closing prices from the stored market history.

250 sessions
$44$37$30$23$16Oct 21Apr 21Oct 19
STOCK RESEARCH · EDITORIAL ANALYSIS

Roivant Sciences Ltd. (ROIV): Investment Research & Business Outlook

A research-led explanation of the company, its financial evidence, valuation context and risks—not just a list of market numbers.

Research note

What the available evidence tells us

The latest stored quote for Roivant Sciences Ltd. (ROIV) is 34.70, timestamped 10/19/2026, 4:00:00 AM. A quote is a point-in-time observation; it does not, by itself, explain why the price moved or establish whether the shares are attractive.

Business and financial quality

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others. Stored fundamentals include 23 usable headline metrics. These should be read across several reporting periods and compared with peers before drawing a conclusion about business quality.

Valuation: context matters

A usable trailing P/E value is not currently stored. Without a verified valuation metric and a relevant comparison set, this page does not label the shares cheap or expensive.

Price trend and quantitative outlook

The chart is based on 250 stored daily price observations. Historical performance describes what happened over that period; it is not a guarantee of future returns. The current stored quantitative model signal is “neutral”. Treat model outputs as scenarios with uncertainty, not as certain targets or personalized advice.

Key risks and what to watch next

Risk records exist for this company; review the risk and performance section below for the available volatility, drawdown and risk-adjusted measures. The next useful evidence to review is the company’s next reported financial results, changes in forward estimates, and primary-source disclosures.

Editorial integrity: this summary uses fields available in the current database. Missing evidence is called out rather than filled with invented facts.

What the numbers mean for investors

Business quality

A reliable revenue-growth reading is not available or is not positive in the latest stored snapshot. Review multiple reporting periods before judging the growth trajectory.

Profitability

Margin data is incomplete. Revenue alone cannot show whether the company converts sales into sustainable profit.

Valuation

A usable P/E value is not stored. Avoid calling the shares cheap or expensive until earnings and valuation data can be verified.

Price trend

The latest quote can be compared with the 20-, 50- and 200-day moving averages (35.39, 36.60, and 30.85). Moving averages describe trend, not intrinsic value, and can lag sudden market changes.

Bull case, bear case and evidence to watch

Bull case

The bullish case needs confirmation from reported revenue growth, cash generation, and future company disclosures; the current snapshot does not establish those conditions together.

Bear case

Potential downside still includes weaker demand, margin compression, competition, execution issues, or a broad market sell-off. Company-specific evidence is needed to quantify these risks.

What to watch next

Track the next earnings release, changes in revenue and margin trends, cash flow, management guidance, analyst estimate revisions, and primary-source filings. Update the thesis when new evidence arrives rather than relying on one ratio or forecast.

These interpretations are rule-based explanations of the stored fields, not independently verified company-specific forecasts. Missing data is not treated as zero; all investment cases remain conditional on new evidence.

US Market AI Research Desk · Data/research timestamp: Oct 19, 2026 · Methodology & disclaimer
QUANTITATIVE RESEARCH

Stock forecast and analysis: price outlook

Forecasts are model outputs, not promises or personalized investment advice.

neutral
HorizonModel targetExpected changeSignalConfidence score
24H34.60-0.27%neutral81
7D34.34-1.03%neutral81
30D33.74-2.75%bearish81
90D32.82-5.42%bearish81

Long-term model scenarios

Latest stored scenario per future target year. Bear, base and bull prices are model scenarios, not guaranteed targets. The relative model score is not a calibrated probability; uncertainty rises materially for distant years.

Target yearBase caseBear caseBull caseExpected CAGRRelative model scoreSignal
202735.0735.0135.76-1.3%62long-term-neutral
203036.0535.2138.710.36%61long-term-neutral
203542.6638.9949.332.05%59long-term-positive
204053.4345.1066.192.96%57long-term-positive
205085.0060.98120.663.7%52long-term-positive
COMPANY FUNDAMENTALS

Financial performance and company fundamentals

Reported fields from the current fundamentals snapshot.

Revenue1.44MTotal sales reported for the period; compare growth across several periods.
Operating income-365.99MInterpret alongside the company’s history, sector peers, reporting period and data source.
Net income-189.84MInterpret alongside the company’s history, sector peers, reporting period and data source.
Operating margin-25380.93%Share of revenue left after operating expenses, before interest and taxes.
Net margin-13164.84%Share of revenue that remains as profit after expenses and taxes.
EBITDA-365.39MInterpret alongside the company’s history, sector peers, reporting period and data source.
EBIT-365.99MInterpret alongside the company’s history, sector peers, reporting period and data source.
Cash & equivalents1.25BInterpret alongside the company’s history, sector peers, reporting period and data source.
Total assets5.31BInterpret alongside the company’s history, sector peers, reporting period and data source.
Total liabilities384.62MInterpret alongside the company’s history, sector peers, reporting period and data source.
Shareholders equity4.23BInterpret alongside the company’s history, sector peers, reporting period and data source.
Current assets4.74BInterpret alongside the company’s history, sector peers, reporting period and data source.
Current liabilities283.6MInterpret alongside the company’s history, sector peers, reporting period and data source.
Operating cash flow-270.5MInterpret alongside the company’s history, sector peers, reporting period and data source.
Capital expenditure419KInterpret alongside the company’s history, sector peers, reporting period and data source.
Free cash flow-270.92MCash remaining after operating needs and capital expenditure; can support investment or shareholder returns.
FCF margin-18788.00%Interpret alongside the company’s history, sector peers, reporting period and data source.
Return on equity-4.49%Profit generated relative to book equity; leverage and one-off gains can distort it.
Return on assets-3.58%Interpret alongside the company’s history, sector peers, reporting period and data source.
Price / book6.04Interpret alongside the company’s history, sector peers, reporting period and data source.
Shares outstanding720,776,739Interpret alongside the company’s history, sector peers, reporting period and data source.
Book value / share5.87Interpret alongside the company’s history, sector peers, reporting period and data source.
FCF / share-0.38Interpret alongside the company’s history, sector peers, reporting period and data source.
Market cap25.54BMarket value of outstanding shares, not the same as enterprise value.
52-week high42.50Highest stored price over the rolling year; not a fair-value estimate.
52-week low17.28Lowest stored price over the rolling year; not a support guarantee.
Average volume6,334,280Typical shares traded; helps assess liquidity but can change around events.
TECHNICALS

Technical indicators

Latest stored daily indicator snapshot; unavailable indicators are omitted.

Oct 20, 2026
RSI (14)44.98Momentum oscillator from 0–100; extreme readings are context, not automatic buy/sell signals.
SMA 2035.39Average closing price over about 20 trading sessions; a short-term trend reference.
SMA 5036.60Average closing price over about 50 sessions; often used to assess medium-term direction.
SMA 10034.80Interpret alongside the company’s history, sector peers, reporting period and data source.
SMA 20030.85Average closing price over about 200 sessions; a longer-term trend reference.
EMA 2035.29Interpret alongside the company’s history, sector peers, reporting period and data source.
EMA 5035.75Interpret alongside the company’s history, sector peers, reporting period and data source.
EMA 20030.54Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD-0.89Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD signal-0.73Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD histogram-0.15Difference between MACD and its signal line; sign and changes indicate momentum shifts.
Bollinger upper37.91Interpret alongside the company’s history, sector peers, reporting period and data source.
Bollinger middle35.39Interpret alongside the company’s history, sector peers, reporting period and data source.
Bollinger lower32.87Interpret alongside the company’s history, sector peers, reporting period and data source.
Stochastic42.98Interpret alongside the company’s history, sector peers, reporting period and data source.
Stochastic signal26.37235062461906Interpret alongside the company’s history, sector peers, reporting period and data source.
Williams %R-57.02Interpret alongside the company’s history, sector peers, reporting period and data source.
CCI-60.91Interpret alongside the company’s history, sector peers, reporting period and data source.
MFI38.29Interpret alongside the company’s history, sector peers, reporting period and data source.
ROC-2.25%Interpret alongside the company’s history, sector peers, reporting period and data source.
OBV232.86MInterpret alongside the company’s history, sector peers, reporting period and data source.
Momentum-3.02Interpret alongside the company’s history, sector peers, reporting period and data source.
Volatility+34.21%Interpret alongside the company’s history, sector peers, reporting period and data source.
ATR1.16Average true range estimates recent price movement size, not direction.
ADX45.27Measures trend strength, not whether the trend is bullish or bearish.
Support level33.00Interpret alongside the company’s history, sector peers, reporting period and data source.
Resistance level39.17Interpret alongside the company’s history, sector peers, reporting period and data source.
TrendneutralInterpret alongside the company’s history, sector peers, reporting period and data source.
REPORTED RESULTS

Financial statements, earnings history and estimate revisions

Recent normalized financial statement records.

Showing up to 60 recent statement records. Reported periods and statement types are preserved; blank values are not estimated. Contradictory zero sentinels are withheld instead of presented as verified facts.

PeriodStatementFiscal periodBasisRevenueCost of revenueGross profitOperating incomeNet incomeBasic EPSDiluted EPSCashTotal assetsTotal liabilitiesDebtEquityOperating cash flowCapexFree cash flowSource
Jun 30, 2026balance sheetFY-2026annual———————1.25B5.31B384.62M—4.23B———SEC_XBRL_BULK
Jun 30, 2026balance sheetFY-2026-Q1annual———————1.25B5.31B384.62M—————3spread
Jun 30, 2026cash flowFY-2026-Q1quarterly————————————-270.5M419K-270.92M3spread
Jun 30, 2026income statementFY-2026-Q1quarterly1.44M——-365.99M-189.84M——————————3spread

Financial metric history

PeriodRevenue growthGross marginOperating marginNet marginROEROIC
Jun 30, 2026——-25380.93%-13164.84%-4.49%—

Earnings history

These are SEC-reported financial facts grouped by fiscal period. The displayed date is the SEC filing/observation date, not a verified earnings announcement or release date. Use the company’s investor-relations calendar for confirmed earnings-release timing.

SEC filing / observation dateFiscal periodEPS reportedEPS estimateRevenue reportedRevenue estimate
Aug 6, 2026Q1-0.26—1.44M—
May 20, 2026FY-0.54—8.26M—
Feb 6, 2026Q3-0.38—2M—
Nov 10, 2025Q2-0.17—1.57M—
Aug 11, 2025Q1-0.33—2.17M—
May 29, 2025FY-0.24—29.05M—
VALUATION

Stock valuation: P/E, forward P/E and multiples

Multiples shown only when the database has a usable value.

Price / book6.04
Enterprise value24.3B

Peer comparisons are withheld until a comparable industry group and a reliable peer set are verified.

LATEST DEVELOPMENTS

News and company updates

Stories linked to this stock in the current database.

RISK CONTEXT

Risk and performance profile

Computed risk/performance records; not a recommendation. Mathematically uninterpretable or extreme ratios are withheld rather than displayed as reliable facts.

Volatility+30.47%
Beta1.01
ATR1.23
Maximum drawdown-18.18%
Sharpe ratio1.93
Sortino ratio2.82
Debt / equity0.08
Current ratio16.72
1-day return+3.60%
5-day return+0.08%
1-month return+1.72%
3-month return+1.14%
6-month return+25.41%
YTD return+63.73%
1-year return+119.73%
All-time return+205.24%
RESEARCH EVIDENCE

Source data and research records

Expandable evidence tables keep the main page focused while preserving detailed data.

Institutional holders and ownership

Showing up to 50 recent holder records. Values failing a basic implied-price check are withheld, not silently corrected.

PeriodFiledHolderCIKSharesValueOwnershipShares changeChange %Source
Jun 30, 2026Aug 5, 2026Parallel Advisors, LLC16900102,05472.69K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Legal & General Group Plc764068329,38711.66M———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026US BANCORP \DE\361045,065179.25K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026MANUFACTURERS LIFE INSURANCE COMPANY, THE9280472,988,121105.75M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026State of Tennessee, Department of Treasury1587973181,2446.41M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Quinn Opportunity Partners LLC163327521,500760.89K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Cerity Partners LLC156647525,922917.38K———SEC_13F_DATASET
Jun 30, 2026Aug 5, 2026Janney Montgomery Scott LLC132994879,550Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 5, 2026Cynosure Group, LLC17634099,705343.46K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026AlphaGrep UK Ltd214898812,745451.05K———SEC_13F_DATASET
Jun 30, 2026Jul 15, 2026Aventura Private Wealth, LLC20744181244.39K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026STEMPOINT CAPITAL LP1952142348,40812.33M———SEC_13F_DATASET
Jun 30, 2026Jul 14, 2026Cache Advisors, LLC2052593538,60019.06M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Laird Norton Wetherby Trust Company, LLC7232046,347224.62K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026SECTORAL ASSET MANAGEMENT INC127441361,1002.16M———SEC_13F_DATASET
Jun 30, 2026Jul 27, 2026Bare Financial Services, Inc2009426561.98K———SEC_13F_DATASET
Jun 30, 2026Aug 11, 2026PROFUND ADVISORS LLC112991956,7512.01M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026LORD, ABBETT & CO. LLC728100235,403Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026JONES FINANCIAL COMPANIES LLLP81591715,154516.3K———SEC_13F_DATASET
Jun 30, 2026Aug 4, 2026TD PRIVATE CLIENT WEALTH LLC155101769824.7K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Federation des caisses Desjardins du Quebec202229732,4571.15M———SEC_13F_DATASET
Jun 30, 2026Aug 4, 2026North Dakota State Investment Board206403912,628446.91K———SEC_13F_DATASET
Jun 30, 2026Jul 27, 2026V-Square Quantitative Management LLC194323967924.03K———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026CAPITOLIS LIQUID GLOBAL MARKETS LLC2094379237,0008.39M———SEC_13F_DATASET
Jun 30, 2026Jul 10, 2026DiNuzzo Private Wealth, Inc.1994563672.37K———SEC_13F_DATASET
Jun 30, 2026Aug 4, 2026Brooklyn FI, LLC19161237244———SEC_13F_DATASET
Jun 30, 2026Jul 10, 2026JFS WEALTH ADVISORS, LLC15680682478.74K———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026Patient Square Capital LP18192578,020,928283.86M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026MILLENNIUM MANAGEMENT LLC1273087700,49424.79M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026HANTZ FINANCIAL SERVICES, INC.107106134,865Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026Cetera Investment Advisers1666741174,1156.16M———SEC_13F_DATASET
Jun 30, 2026Aug 4, 2026State of New Jersey Common Pension Fund D1483066150,4205.32M———SEC_13F_DATASET
Jun 30, 2026Aug 11, 2026ProShare Advisors LLC135795541,3711.46M———SEC_13F_DATASET
Jun 30, 2026Jul 9, 2026Marquette Asset Management, LLC13950672679.45K———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026Vanguard Investments Australia, Ltd.1550100118,4174.19M———SEC_13F_DATASET
Jun 30, 2026Jul 9, 2026Edge Wealth Management LLC156716390,2283.19M———SEC_13F_DATASET
Jun 30, 2026Jul 8, 20263 FACTOR INDEXING, LLC21351699319———SEC_13F_DATASET
Jun 30, 2026Jul 8, 2026THURSTON, SPRINGER, MILLER, HERD & TITAK, INC.31993345516.1K———SEC_13F_DATASET
Jun 30, 2026Aug 11, 2026VestGen Advisors, LLC205013036,9121.31M———SEC_13F_DATASET
Jun 30, 2026Jul 8, 2026Ledgewood Wealth Advisors, LLC206404332,9701.17M———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026RHUMBLINE ADVISERS11154181,178,78941.72M———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026Rakuten Securities, Inc.2009539271———SEC_13F_DATASET
Jun 30, 2026Jul 8, 2026ELEVATION WEALTH PARTNERS, LLC19762561154.07K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Scientech Research LLC20115567,016248.3K———SEC_13F_DATASET
Jun 30, 2026Aug 6, 2026AXQ CAPITAL, LP191690839,7121.41M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026CAPTRUST FINANCIAL ADVISORS151202418,169642.99K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Pine Ridge Advisers LLC1845915276,5309.79M———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026EntryPoint Capital, LLC19925197,144252.83K———SEC_13F_DATASET
Jun 30, 2026Jul 23, 2026Sivia Capital Partners, LLC201203212,420439.54K———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026Affinity Asset Advisors, LLC17731953,750,000132.71M———SEC_13F_DATASET
PeriodShares outstandingInstitutional ownershipInsider ownership
Jun 30, 2026720,776,739+67.44%+12.70%
Insider transactions

Reported transaction values and remaining holdings are shown only when supplied by the source.

Transaction dateFiledInsiderTitleTypeCodeSharesPriceReported valueShares afterFilingSource
Oct 1, 2026Oct 5, 2026Roivant Sciences Ltd.—DispositionD8,967,3835.0044.84M29,880,079Open filingSEC_FORM_3_4_5
Oct 1, 2026Oct 5, 2026Epperly Melissa B,—Option ExerciseM17,7504.4679.17K32,704Open filingSEC_FORM_3_4_5
Oct 1, 2026Oct 5, 2026Epperly Melissa B,—SaleS16,85036.08607.95K15,854Open filingSEC_FORM_3_4_5
Oct 1, 2026Oct 5, 2026Epperly Melissa B,—SaleS90036.5732.91K14,954Open filingSEC_FORM_3_4_5
Sep 30, 2026Oct 2, 2026Sukhatme MayukhPresident & CIOTax WithholdingF46,87936.571.71M18,583,860Open filingSEC_FORM_3_4_5
Sep 30, 2026Oct 2, 2026Gline MatthewCEOTax WithholdingF76,17136.572.79M16,583,774Open filingSEC_FORM_3_4_5
Sep 30, 2026Oct 2, 2026Venker EricPresident & Immunovant CEOOption ExerciseM200,0003.85770K1,799,154Open filingSEC_FORM_3_4_5
Sep 30, 2026Oct 2, 2026Venker EricPresident & Immunovant CEOSaleS200,00036.627.32M1,599,154Open filingSEC_FORM_3_4_5
Sep 30, 2026Oct 2, 2026Torti FrankPresident and Vant ChairTax WithholdingF40,30936.571.47M13,495,893Open filingSEC_FORM_3_4_5
Sep 20, 2026Sep 22, 2026Pulik RichardCFOTax WithholdingF2,12939.7784.67K269,681Open filingSEC_FORM_3_4_5
Sep 20, 2026Sep 22, 2026Humes JenniferChief Accounting OfficerTax WithholdingF3,88039.77154.31K106,419Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026MOMTAZEE JAMES C—Award/GrantA5,0540.000111,959Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026MOMTAZEE JAMES C—Award/GrantA10,5310.00010,531Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026Fitzgerald Meghan—Award/GrantA5,0540.00041,162Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026Fitzgerald Meghan—Award/GrantA10,5310.00010,531Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026MANCHESTER KEITH S—Award/GrantA5,0540.0001,753,457Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026MANCHESTER KEITH S—Award/GrantA10,5310.00010,531Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026Gold Daniel Allen—Award/GrantA5,0540.0008,965,815Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026Gold Daniel Allen—Award/GrantA10,5310.00010,531Open filingSEC_FORM_3_4_5
Sep 16, 2026Sep 18, 2026Oren Ilan—Award/GrantA5,0540.000123,680Open filingSEC_FORM_3_4_5
SEC filings

Showing up to 30 latest filings. Open the original SEC document when a URL is available.

FiledAcceptedFormDescriptionReporting periodAccessionSEC document
Oct 5, 2026—4FORM 4Oct 1, 20260001140361-26-038692View filing
Oct 5, 2026—4FORM 4Oct 1, 20260001807359-26-000018View filing
Oct 2, 2026—4FORM 4Sep 30, 20260001635088-26-000108View filing
Oct 2, 2026—4FORM 4Sep 30, 20260001140361-26-038475View filing
Oct 2, 2026—4FORM 4Sep 30, 20260001140361-26-038474View filing
Oct 2, 2026—4FORM 4Sep 30, 20260001635088-26-000109View filing
Sep 30, 2026—144——0001965301-26-000150View filing
Sep 22, 2026—4FORM 4Sep 20, 20260001140361-26-037363View filing
Sep 22, 2026—4FORM 4Sep 20, 20260001635088-26-000104View filing
Sep 18, 2026—4FORM 4Sep 16, 20260001209181-26-000007View filing
Sep 18, 2026—4FORM 4Sep 16, 20260001349297-26-000010View filing
Sep 18, 2026—8-K8-KSep 16, 20260001635088-26-000095View filing
Sep 18, 2026—4FORM 4Sep 16, 20260001140361-26-037158View filing
Sep 18, 2026—4FORM 4Sep 16, 20260001635088-26-000102View filing
Sep 18, 2026—4FORM 4Sep 16, 20260001635088-26-000099View filing
Sep 18, 2026—4FORM 4Sep 16, 20260001807359-26-000016View filing
Sep 17, 2026—4FORM 4Sep 15, 20260001807359-26-000014View filing
Sep 17, 2026—4FORM 4Sep 15, 20260001349297-26-000008View filing
Sep 15, 2026—144——0001950047-26-009506View filing
Sep 15, 2026—144——0001950047-26-009495View filing
Sep 14, 2026—4FORM 4Sep 10, 20260001140361-26-036535View filing
Sep 14, 2026—4FORM 4Sep 10, 20260001635088-26-000092View filing
Sep 14, 2026—4FORM 4Sep 10, 20260001807359-26-000012View filing
Sep 14, 2026—4FORM 4Sep 10, 20260001349297-26-000006View filing
Sep 14, 2026—4FORM 4Sep 10, 20260001209181-26-000005View filing
Sep 10, 2026—4FORM 4Sep 8, 20260001140361-26-036246View filing
Sep 8, 2026—144——0001950047-26-009199View filing
Sep 8, 2026—8-K8-KSep 8, 20260001140361-26-035859View filing
Sep 1, 2026—4FORM 4Aug 28, 20260001140361-26-035375View filing
Aug 28, 2026—144——0001965301-26-000133View filing
Quarterly and monthly research
PeriodResearch summary
Jun 30, 2026Latest reported fundamentals for fiscal period FY-2026-Q1. Revenue: $1442000. Operating margin: -25380.93%. Net margin: -13164.84%. Free cash flow: $-270923000.
Jun 30, 2026Latest reported fundamentals for fiscal period FY-2026. Revenue: $1442000. Operating margin: -25380.93%. Net margin: -13164.84%. Free cash flow: $-270923000.
MonthResearch summary
Oct 1, 2026Derived monthly snapshot; AI narrative pending
Third-party metrics and ratios

Showing up to 40 recent metric records and 40 ratio records from the query window. Provider periods, units and validity flags are preserved when available.

PeriodReport periodFiscal yearQuarterPeriod typeCategoryValueUnitCurrencyValidSource
Jun 30, 2026Jun 30, 202620271quarterlyunrealized_gain_loss_on_investments_and_derivatives36,637,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyunrealized_gain_loss_on_investments-36,637,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlytotal_revenue1,442,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instanttotal_noncurrent_liabilities9,466,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlylegal_and_regulatory_settlements392,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlysalaries_and_employee_benefits-367,543,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyfair_value_adjustments0—USDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyfx_effect315,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyother_financing_activities-2,517,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyother_operating_activities9,789,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyrepurchases_of_stock-206,729,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620271instantcommon_stock0—USDYes3Spread
Jun 30, 2026Jun 30, 202620271instantnoncontrolling_interests690,596,000—USDYes3Spread
Jun 30, 2026Jun 30, 202620271instantaccounts_payable25,084,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantaccrued_expenses168,740,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantaccumulated_other_comprehensive_income701,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantadditional_paid_in_capital5,130,926,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyamortization_of_debt_costs-5,691,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantcash_and_equivalents1,248,456,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlycash_beginning_of_period1,430,982,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlycash_end_of_period1,260,543,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlychange_in_accounts_payable7,109,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlychange_in_accrued_liabilities-13,911,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlychange_in_fair_value_of_warrant_liabilities0USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlychange_in_income_taxes-10,177,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlychange_in_other_assets-21,968,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlychange_in_other_liabilities7,644,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlychange_in_receivables-1,392,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlycost_of_revenue-284,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantcurrent_assets4,742,080,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantcurrent_liabilities283,603,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlydepreciation_and_amortization600,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyeps_basic-0.26USD/shareUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyeps_diluted-0.26USD/shareUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyincome_before_taxes-294,564,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyincome_tax_expense3,958,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantincome_taxes_payable74,182,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyinterest_income36,922,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantinvestments_at_fair_value444,622,000USDUSDYes3Spread
Jun 30, 2026Jun 30, 202620271instantlease_liability_current12,384,000USDUSDYes3Spread
PeriodReport periodFiscal yearQuarterPeriod typeRatio categoryRatioValuePercentileMissing inputsValidSource
Jun 30, 2026Jun 30, 202620271quarterlyprofitabilitygross_margin_pct0+0.00%gross_profitNo3Spread
Jun 30, 2026Jun 30, 202620271quarterlyleverageinterest_coverage0+0.00%interest_expenseNo3Spread
Jun 30, 2026Jun 30, 202620271quarterlyefficiencyinventory_turnover0+0.00%inventoryNo3Spread
Jun 30, 2026Jun 30, 202620271quarterlyefficiencyreceivables_turnover0+0.00%receivablesNo3Spread
Jun 30, 2026Jun 30, 202620271quarterlyefficiencyasset_turnover0+2.45%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyliquiditycash_ratio4.4+94.53%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlycash_flowcf_margin_pct-18,758.95+0.29%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlycash_flowcf_to_net_income0.93+41.70%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyliquiditycurrent_ratio16.72+96.53%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyleveragedebt_to_assets0.07+4.75%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlysectordebt_to_ebitda-1.05+20.31%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyleveragedebt_to_equity0.08+14.36%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlysectorebitda_margin_pct-25,339.32+0.26%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyleverageequity_multiplier1.08+14.61%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlycash_flowfree_cash_flow-270,504,000+4.28%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyprofitabilitynet_margin_pct-20,152.98+0.42%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlycash_flowoperating_cf_ratio-0.95+5.41%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyprofitabilityoperating_margin_pct-25,380.93+0.39%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyliquidityquick_ratio16.72+96.53%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyprofitabilityroa_pct-5.48+13.20%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyprofitabilityroe_pct-5.9+15.85%—Yes3Spread
Jun 30, 2026Jun 30, 202620271quarterlyliquidityworking_capital4,458,477,000+94.66%—Yes3Spread
Mar 31, 2026Mar 31, 202620264annualprofitabilitygross_margin_pct0+0.00%gross_profitNo3Spread
Mar 31, 2026Mar 31, 202620264quarterlyprofitabilitygross_margin_pct0+0.00%gross_profitNo3Spread
Mar 31, 2026Mar 31, 202620264quarterlyleverageinterest_coverage0+0.00%interest_expenseNo3Spread
Mar 31, 2026Mar 31, 202620264annualleverageinterest_coverage0+0.00%interest_expenseNo3Spread
Mar 31, 2026Mar 31, 202620264quarterlyefficiencyinventory_turnover0+0.00%inventoryNo3Spread
Mar 31, 2026Mar 31, 202620264annualefficiencyinventory_turnover0+0.00%inventoryNo3Spread
Mar 31, 2026Mar 31, 202620264annualefficiencyreceivables_turnover0+0.00%receivablesNo3Spread
Mar 31, 2026Mar 31, 202620264quarterlyefficiencyreceivables_turnover0+0.00%receivablesNo3Spread
Mar 31, 2026Mar 31, 202620264quarterlyefficiencyasset_turnover0+3.95%—Yes3Spread
Mar 31, 2026Mar 31, 202620264annualefficiencyasset_turnover0+1.14%—Yes3Spread
Mar 31, 2026Mar 31, 202620264annualliquiditycash_ratio5.05+98.36%—Yes3Spread
Mar 31, 2026Mar 31, 202620264quarterlyliquiditycash_ratio5.05+90.29%—Yes3Spread
Mar 31, 2026Mar 31, 202620264quarterlycash_flowcf_margin_pct-6,240.52+1.54%—Yes3Spread
Mar 31, 2026Mar 31, 202620264annualcash_flowcf_margin_pct-9,124.71+0.57%—Yes3Spread
Mar 31, 2026Mar 31, 202620264annualcash_flowcf_to_net_income1.89+67.21%—Yes3Spread
Mar 31, 2026Mar 31, 202620264quarterlycash_flowcf_to_net_income-0.44+15.96%—Yes3Spread
Mar 31, 2026Mar 31, 202620264quarterlyliquiditycurrent_ratio18.37+95.55%—Yes3Spread
Mar 31, 2026Mar 31, 202620264annualliquiditycurrent_ratio18.37+98.91%—Yes3Spread
Data quality and provenance

This page does not fill gaps with sample data. Values shown above come from the connected market-data and research tables.

No verified records available for this section yet.
RetrievedDatasetProviderStatus
Oct 8, 2026company_profileUS Market AI / SEC-mapped universeVerified
Identifiers and model evaluation
IdentifierValueSource
cik1635088stocks.cik
tickerROIVstocks.symbol
No verified records available for this section yet.
QUICK ANSWERS

Frequently asked questions

What is ROIV stock's current price?

The latest stored quote for ROIV is 34.70. The quote timestamp is 10/19/2026, 4:00:00 AM. Prices can change during market hours.

What is the ROIV stock forecast and analysis?

The latest available quantitative model signal is “neutral”. Review the forecast horizons alongside the company's reported financials, valuation, technical indicators and risks below; model outputs are estimates, not guarantees or personalized investment advice.

What is the ROIV stock price target?

The forecast table shows stored quantitative model outputs for the available horizons. These are model targets, not necessarily Wall Street analyst consensus; a verified consensus target is not assumed unless explicitly stored.

What is the ROIV stock price prediction for 2030?

A stored long-term model scenario for 2030 is shown in the forecast table. Long-range scenarios are highly uncertain and should be reviewed alongside the model version and assumptions.

What are the bullish and bearish views on ROIV?

A sufficiently detailed analyst-opinion dataset is not currently stored for this stock. The bull and bear cases on this page are conditional evidence-based scenarios, not attributed analyst recommendations.

What is the ROIV stock price prediction for 2026?

A verified 2026 long-term model output is not currently stored for this stock. Check the forecast section for available horizons rather than relying on an unsupported target.

Is ROIV stock overvalued or undervalued?

The database does not currently contain a usable trailing P/E value. Without verified valuation inputs and a suitable comparison set, this page cannot responsibly label the shares overvalued or undervalued.

What is ROIV's P/E ratio?

A usable trailing P/E ratio is not currently available in the stored valuation data.

What is ROIV's 52-week high and low?

The stored 52-week range is 17.28 to 42.50. This describes the recent trading range, not a forecast or a guaranteed support/resistance level.

Does ROIV pay a dividend, and what is its dividend history?

No dividend records are currently stored for this stock. That absence does not prove the company pays no dividend.

When is ROIV's next earnings report?

The latest SEC filing/observation date in this database is Aug 6, 2026. This is not a verified earnings announcement date or a confirmed next-report date; check company investor relations for the official calendar.

How has ROIV stock performed recently?

The price chart uses 250 stored daily observations, and the market snapshot includes the latest available quote. Use the chart to inspect the period shown; past performance does not predict future returns.

Is ROIV stock in a bullish or bearish trend?

The stored technical snapshot classifies the trend as “neutral”. This rule-based label is based on available indicators and is not a standalone buy or sell signal.

What are the main risks of investing in ROIV?

Available risk metrics are shown in the risk and performance section. These metrics do not capture every business, competitive, regulatory or market risk; review company filings and disclosures as well.

Where can I find ROIV's financial statements and earnings history?

Use the Financial Statements section for stored statement records, financial metric history, earnings results and estimate revisions. Coverage depends on the data available for this company.

Does US Market AI provide a guaranteed ROIV price target?

No. Forecasts shown here are quantitative model outputs, not guarantees or personalized financial advice. Missing forecast values are left unavailable rather than filled with invented targets.

KEEP EXPLORING

Related Healthcare stocks

Other active stocks in this sector. This is a directory, not a performance ranking.

Browse all stocks ↗
LLYEli Lilly & Co.Healthcare1.05T market capJNJJohnson & JohnsonHealthcare630.04B market capABBVABBVIE INC.Healthcare483B market capMRKMerck & Co., Inc.Healthcare359.22B market cap
US MARKET AI · STOCK RESEARCH

Data availability varies by company and provider. Missing values are omitted rather than estimated. Forecasts are model outputs and should be independently evaluated.

Research updated Oct 19, 2026 · Research methodology · Disclaimer